Advertisement
Screener

DYADIC INTERNATIONAL INC (DYAI) Executive Pay versus Performance: Pay versus Performance

DYADIC INTERNATIONAL INC Pay versus Performance

The Pay versus Performance table from each proxy statement (Item 402(v)), as tagged in its XBRL, newest proxy first. Each proxy's own figures are kept, so a year restated in a later proxy appears once per proxy. PEO is the principal executive officer; NEO means the other named executive officers (average). Total shareholder return is the value of a $100 investment.

  • 2025-12-31: PEO Mark Emalfarb; PEO total compensation $1.01M; PEO compensation actually paid $518.55K; Other NEO average total compensation $448.25K.
  • 2024-12-31: PEO Mark Emalfarb; PEO total compensation $1.04M; PEO compensation actually paid $1.08M; Other NEO average total compensation $448.67K.
  • 2023-12-31: PEO Mark Emalfarb; PEO total compensation $1.04M; PEO compensation actually paid $1.11M; Other NEO average total compensation $424.94K.
  • 2024-12-31: PEO total compensation $1.04M; PEO compensation actually paid $1.08M; Other NEO average total compensation $448.67K.
Fiscal year endPEOPEO total compensationPEO compensation actually paidOther NEO average total compensationOther NEO average compensation actually paidTotal shareholder returnPeer group total shareholder returnNet incomeCompany-selected measureProxy filed
2025-12-31Mark Emalfarb$1.01M$518.55K$448.25K$239.27K$76.42-$7.40M2026-05-12
2024-12-31Mark Emalfarb$1.04M$1.08M$448.67K$434.73K$39.77-$5.80M2026-05-12
2023-12-31Mark Emalfarb$1.04M$1.11M$424.94K$472.38K$29.93-$6.80M2026-05-12
2024-12-31$1.04M$1.08M$448.67K$434.73K$39.77$5.81M2025-04-29
2023-12-31$1.04M$1.11M$424.94K$472.38K$29.93$6.80M2025-04-29
2022-12-31$1.37M-$435.86K$466.03K$60.13K$22.86$9.74M2025-04-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
BioCardia, Inc. (BCDA)United States$0.016B
Passage BIO, Inc. (PASG)United States$0.015B-0.43
Pluri Inc. (PLUR)$0.014B
INTENSITY THERAPEUTICS, INC. (INTS)United States$0.013B-1.08
BRAINSTORM CELL THERAPEUTICS INC. (BCLI)United States$0.013B-1.05
Jasper Therapeutics, Inc. (JSPR)United States$0.020B-0.37
IN8BIO, INC. (INAB)United States$0.012B-0.76
Estrella Immunopharma, Inc. (ESLA)United States$0.020B
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23